Repligen Corporation (RGEN)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$140.85
-3.09%
Mkt Cap $7.39B
Analyst Ratings
Buy
13
Hold
1
Sell
0
Price Target (24 analysts)
$158.86
Range $142.00 – $200.00
Implied Upside
+12.8%
Consensus $158.86 vs current $140.85